Press release
University of Dundee spinout Amphista Therapeutics today announced the delivery of the first discovery milestone under a collaboration and licence agreement with global biopharmaceutical company Bristol Myers Squibb.
Press release
University of Dundee spinout Amphista Therapeutics today announced the delivery of the first discovery milestone under a collaboration and licence agreement with global biopharmaceutical company Bristol Myers Squibb.
Press release
University of Dundee spinout company Tay Therapeutics has announced a licensing deal potentially worth over $50 million in upfront and milestone payments, plus royalties.
News
Julia has just been awarded with a 'Top Project Award from an Accredited Degree Programme' by the Royal Society of Biology, attending an awards ceremony in London this month.
Press release
Researchers at the University of Dundee have thanked members of the public who funded the purchase of new technology that could lead to new treatments for Parkinson’s disease.
Press release
World-leading and collaborative research undertaken at the University of Dundee has been honoured at one of the Life Sciences sector’s most prestigious award ceremonies.
News
The University of Dundee is working with institutes in Ghana to improve existing drug discovery capacity in the region and establish a drug discovery hub
News
Monday January 30th, 2023 marks the fourth World Neglected Tropical Diseases (NTDs) Day, supporting a global movement to end NTDs.
Press release
A new University of Dundee spinout opportunity hopes to create vaccines against Strep A as well as novel vaccines for other human and animal diseases, while reducing our reliance on antibiotics.
News
Our annual Honours Project Symposium returned as an in-person event for the first time in three years last month.
Press release
A drug developed at the University of Dundee for a neglected tropical disease could be repurposed to treat leukaemia following Fast Track Designation by the U.S. Food and Drug Administration (FDA).
Press release
University of Dundee spinout Amphista Therapeutics has received a boost in its efforts to develop new drugs for neurogenerative diseases such as dementia.
Press release
Scientists have designed a novel molecule capable of destroying an as-yet undruggable cancer-causing protein – and are making it available for researchers around the world to use in their own work, free of charge
News
Two Life Sciences students have been recognised in this year’s Global Undergraduate Awards (UA). Nicole Coutinho Garrido was named as Regional Winner (Europe) while Dana Cheung was Highly Commended.
Press release
University of Dundee spinout Amphista Therapeutics has been designated as one of the world’s most promising biotechnology companies.
Press release
The University of Dundee and Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents, will partner to commercialise technology developed at Dundee that enhances the understanding of undruggable diseases.
Press release
Two sisters will make the University of Dundee’s Graduation celebrations a family affair this week.
Impact case study
Shaping the future of commercial drug development and driving global pharmaceutical investment.
Press release
University of Dundee spinout Amphista Therapeutics will work with global biopharmaceutical companies as part of strategic collaborations potentially worth more than $2 billion.
Feature
Pawat Piyakitcharoen was one of the first students to study one of the new Life Sciences taught postgraduate courses. He explains how mixing science with business provided him with valuable knowledge and skills.
News
Amphista Therapeutics, the spin out company from the lab of Professor Alessio Ciulli, was awarded the ‘Financing Deal of the Year’ award 2021 at the Scrip Awards last month. This was in recognition of their $53M Series B funding.